Ingenza is working with researchers based at the Hartree Centre on molecular simulation techniques with the potential to reduce the time and costs associated with bringing new drug designs to market.
Improving personalised disease diagnostics
By analysing microbiome data, IBM Research scientists based at the STFC Hartree Centre are working to predict whether an individual has an illness, a predisposition to a disease, or how a disease has developed in a non-invasive way.
Pharmaceutical product design goes digital
Working with major names in the industry, the Hartree Centre is a partner in the powerful ADDoPT collaboration that aims to secure the UK’s place at the forefront of new pharmaceutical development.
Advancing disease mapping techniques
Healthcare company GSK is using our computing expertise to identify connections between different genes and diseases, with a view to developing more effective treatments.